{"title": "PPARgamma agonist and platinum-based drug effect on adenocarcinoma cell line", "description": "Analysis of NSCLC adenocarcinoma cells treated with rosiglitazone, carboplatin, or both. Rosiglitazone is an agonist of the nuclear receptor PPARgamma. Results provide insight into the molecular basis of the synergy observed between rosiglitazone and platinum-based drugs in cancer models.", "type": "Expression profiling by array", "pubmed_id": "17482130", "platform": "GPL96", "platform_organism": "Homo sapiens", "platform_technology_type": "in situ oligonucleotide", "feature_count": "22283", "sample_organism": "Homo sapiens", "sample_type": "RNA", "channel_count": "1", "sample_count": "8", "value_type": "count", "reference_series": "GSE7035", "order": "none", "update_date": "May 08 2007", "subsets": [{"dataset_id": "GDS2705", "description": "control", "sample_id": ["GSM162889", "GSM162890"], "type": "agent", "id": "GDS2705_1"}, {"dataset_id": "GDS2705", "description": "rosiglitazone", "sample_id": ["GSM162891", "GSM162892"], "type": "agent", "id": "GDS2705_2"}, {"dataset_id": "GDS2705", "description": "carboplatin", "sample_id": ["GSM162893", "GSM162894"], "type": "agent", "id": "GDS2705_3"}, {"dataset_id": "GDS2705", "description": "rosiglitazone plus carboplatin", "sample_id": ["GSM162895", "GSM162896"], "type": "agent", "id": "GDS2705_4"}], "taxid": "9606", "genes": 14063, "aggregation_function": "mean", "name": "GDS2705", "version": 1.0, "instances": "8", "variables": 14065, "target": "", "gene_as_attribute_name": true, "gene_id_attribute": "Entrez ID", "url": "http://file.biolab.si/geo/GDS2705.tab", "compression": "gz"}